학술논문

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
Document Type
Article
Source
Journal of Infectious Diseases. 2023 Supplement, Vol. 288, pS77-S82. 6p.
Subject
*COVID-19 treatment
*CLINICAL trial registries
*THERAPEUTICS
*OUTPATIENTS
*MONOCLONAL antibodies
Language
ISSN
0022-1899
Abstract
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410. [ABSTRACT FROM AUTHOR]